Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Usability, Immediate, and 30 Day Effect of External Neuromodulation With iTEAR100 Generation 2 in Dry Eye Patients

NCT05304637 is registered in ClinicalTrials.gov with Olympic Ophthalmics, Inc. as lead sponsor.

NCT NCT05304637
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05304637 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Usability, Immediate, and 30 Day Effect of External Neuromodulation With iTEAR100 Generation 2 in Dry Eye Patients
Lead sponsor
Olympic Ophthalmics, Inc.
Phase
Phase 4
Overall status
Unknown status
Start date
March 1, 2022
Completion date
July 1, 2022
Enrollment
30 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

dry eye